The device, called NEO, records neuronal activity and translates it to movements made a metal glove worn by a patient.
An expanded federal library of chemical fingerprints helps scientists identify unknown substances found in forensic evidence, ...
AHA responds to Information Collection Request about the Health Resources and Services Administration’s proposed 340B Rebate Model Program.
NewcelX Ltd. (“NewcelX”; Nasdaq: NCEL), a clinical-stage regenerative medicine company developing stem-cell-derived therapies, today announced that the Brazilian Patent and Trademark Office has issued ...
FDA sets PDUFA target action date of May 1, 2027NEW YORK, July 15, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a ...
More than a decade ago, a handful of scientists, entrepreneurs, and investors began laying the groundwork for what has become ...
Investor's Business Daily on MSN
Biogen slumps as Alzheimer's study leaves 'more questions than answers'
Biogen and Ionis said Tuesday their tau-targeting Alzheimer's treatment slowed cognitive decline by 26% over the course of 18 months.
Intellia Therapeutics looks overvalued as Lonvo-z & Nex-z face regulatory, safety and commercial hurdles plus cash ...
After speedrunning a series of major manufacturing milestones in the past year and a half, the “biotech floodgates” have ...
Ever bought a new type of soda and realized it was an herbal “mood” drink or “social tonic?” They’re sold next to soft drinks, but these drinks contain herbal supplements, some of which can interact ...
The FDA has proposed a new rule that would seek to eliminate the adequate provision guidance in pharma DTC ads.
With PAT, pharmaceutical manufacturers achieve real-time process control, enhancing drug quality and accelerating the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results